Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348439 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
A Phase 2 study, sponsored by Bausch & Lomb Incorporated.
- Terminated
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT00348439: Clinical Trial Phase 2 study, sponsored by Bausch & Lomb Incorporated.
NCT00348439 is a Phase 2 study that was terminated before completion, run by Bausch & Lomb Incorporated. The registered enrollment target is 29 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348439, a Phase 2 study, was terminated before completion, sponsored by Bausch & Lomb Incorporated.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.
Primary Outcome
PVD at the disc and macula post plamin injection
Interventions
- DRUG Vehicle
- DRUG Plasmin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Why NCT00348439 stopped before completion
NCT00348439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT00348439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00348439 about?
NCT00348439 is a clinical study titled "Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment". Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.
What is the current status of trial NCT00348439?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2006-04. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00348439?
The interventions under investigation include: Vehicle (DRUG), Plasmin (DRUG).
Who is sponsoring clinical trial NCT00348439?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00348439's enrollment target sits among peer trials
29 1669th of 2000 higher than 324 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia